Campus your proton
therapy community
  • Log in
Menu
  • About Campus
  • Resources
    • All resources
    • Webinars
    • Podcasts
    • User cases
    • White Papers
    • Publications
    • User meetings
  • Events
  • Forums
  • Training
  • Connect

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event (0)
  • Podcast (0)
  • Publications (77)
  • Training (0)
  • User case (2)
  • User meeting (1)
  • Webinar (4)
  • White paper (1)
Key content topics
Key audience
  • Advanced (0)
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (7)
  • Breast (1)
  • Gastro-intestinal (2)
  • Genito-urinary (2)
  • Head and neck (73)
  • Hodgkin and Non-Hodgkin lymphoma (0)
  • Ocular (2)
  • Pediatric (8)
  • Reirradiation (3)
  • Sarcomas (0)
  • Thoracic (3)
  • Reset filters
  • (-) Head and neck

Show & Tell #1: Head & Neck

19/11/2020
/ User Meeting
/
Head and neck
IMPT
UPENN
Model-based

Dr Alexander Lin, Medical Director at Penn Medicine's Roberts Proton Therapy Center...

Future technological developments in proton therapy - A predicted technological breakthrough

08/07/2021
/ Publications
/
ARC therapy
Pencil beam scanning
Head and neck
Flash Proton Therapy
Flash Irradiation

This article presents an overview of on-going technical developments and innovations that the authors felt most important today, as well as those that have the...

Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience A

08/06/2021
/ Publications
/
Head and neck
Reirradiation
Oropharyngeal Cancer
Paranasal sinus tumors
Overall Survival
Toxicity

A study by the MD Anderson group evaluated the outcomes of 573 patients treated at the institute. Oropharynx (33.3%; n = 191), paranasal sinus (11%; n = 63)...

A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer

08/06/2021
/ Publications
/
Nasopharynx
Oncology
PBT
IMRT
Head and neck
Mucositis
Overall Survival

This review examined 9 original studies and found that the oncologic outcomes of PBT were similar to IMRT with 2-year local and regional progression-free...

A Systematic Review on Re-irradiation with Charged Particle Beam Therapy in the Management of Locally Recurrent Skull Base and Head and Neck Tumors

08/06/2021
/ Publications
/
Reirradiation
Necrosis
Head and neck
skull base
Toxicity

A review examined a total of 26 original studies (15 protons, 10 carbon ions, and 1 helium/neon studies) involving a total of 1,118 patients (437 with protons...

A Review of Particle Therapy for Skull Base Tumors: Modern Considerations and Future Directions

08/06/2021
/ Publications
/
skull base
Head and neck
Chordoma and Chondrosarcoma
Malignancies
A review on proton therapy for skull base tumors including chordoma and chondrosarcoma, pituitary adenoma and acoustic neuroma. Proton therapy for skull base...

Spot Scanning Proton Therapy for Sinonasal Malignant Tumors

08/06/2021
/ Publications
/
Sinonasal
Head and neck
Toxicity
Malignancies

A study from Japan reported outcomes of 62 patients with sinonasal tumors treated with protons to 60 GyRBE in 15 fractions or 60.8 GyRBE in 16 fractions for...

Long-term Outcomes from Proton Therapy for Sinonasal Cancers

08/06/2021
/ Publications
/
Sinonasal
Passive scattering
Hypofractionation
Chemotherapy
Head and neck
Necrosis
Clinical Outcomes
Overall Survival

A study by the Jacksonville group reported clinical outcomes of 143 patients with nonmetastatic sinonasal cancers treated with primary (18%; n = 26) or adjuvant...

Clinical Review of Proton Therapy in the Treatment of Unilateral Head and Neck Cancers

08/06/2021
/ Publications
/
Head and neck
Salivary Gland Cancer
Skin malignancies
skull base
Oropharyngeal Cancer
Reirradiation
Toxicity

In select clinical scenarios of well-lateralized tumors, radiotherapy can be delivered to the primary tumor or tumor bed and the ipsilateral nodal regions. This...

Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes

08/06/2021
/ Publications
/
Salivary Gland Cancer
Clinical Outcomes
PBT
Head and neck
Mucositis
Toxicity

A study by the MD Anderson group reported clinical outcomes of 72 patients with major salivary gland cancers (SGCs) treated by PBT. Sixty-three patients (88%)...

Pagination

    • Current page 1
    • Page 2
    • Page 3
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
Footer menu
  • About Campus
  • Resources
  • Forums
  • Training
  • Connect
  • Back to IBA Proton Therapy
Life Science
Footer Bottom
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies